Farnesoid X receptor: from structure to potential clinical applications.
Pellicciari
Roberto
R
Dipartimento di Chimica e Tecnologia del Farmaco, Università di Perugia, Via del Liceo 1, I-06123 Perugia, Italy. rp@unipg.it
Costantino
Gabriele
G
Fiorucci
Stefano
S
D000818:Animals; D001647:Bile Acids and Salts / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D002318:Cardiovascular Diseases / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D008024:Ligands; D008958:Models, Molecular; D017434:Protein Structure, Tertiary; D018160:Receptors, Cytoplasmic and Nuclear / Q000737:chemistry* / Q000187:drug effects* / Q000378:metabolism; D014157:Transcription Factors / Q000737:chemistry* / Q000187:drug effects* / Q000378:metabolism; D000099150:Receptor, Farnesoid X-Activated
D001647:Bile Acids and Salts; D004268:DNA-Binding Proteins; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D000099150:Receptor, Farnesoid X-Activated